Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 3, 2005, Pages 165-171

  Xu, D ^a   Zhang, Z ^a   Jin, L ^a   Chu, F ^a   Mao, Y ^a   Wang, H ^a   Liu, M ^b   Wang, M ^a   Zhang, L ^a   Gao, G F ^c   Wang, F S ^a  

^a BEIJING 302 HOSPITAL   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RIBAVIRIN; STEROID; VIRUS RNA;

ADOLESCENT; ADULT; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; HUMAN; HUMAN CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SARS CORONAVIRUS; SCHOOL CHILD; SEROCONVERSION; SEVERE ACUTE RESPIRATORY SYNDROME; URINE; VIRUS CULTURE; VIRUS DETECTION; VIRUS SHEDDING;

ADULT; AGED; ANTIBODIES, VIRAL; CONVALESCENCE; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; RNA, VIRAL; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; TIME FACTORS;

EID: 20244387843     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1299-5     Document Type: Article

References (27)

1. World Health Organization (2004) Summary of probable SARS with onset of illness from 1 November 2002 to 31 July 2003. Available at: http://www.who.int/ csr/sars/country/table2004_04_21/en/. Cited 8 May 2004
2. Tambyah PA (2004) SARS: responding to an unknown virus. Eur J Clin Microbiol Infect Dis 23:589-595
3. Drosten C, Gunther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A, Burguiere AM, Cinatl J, Eickmann M, Escriou N, Grywna K, Kramme S, Manuguerra JC, Muller S, Rickerts V, Sturmer M, Vieth S, Klenk HD, Osterhaus AD, Schmitz H, Doerr HW (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348:1967-1976
4. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE, Dowell SF, Ling AE, Humphrey CD, Shieh WJ, Guarner J, Paddock CD, Rota P, Fields B, DeRisi J, Yang JY, Cox N, Hughes JM, LeDuc JW, Bellini WJ, Anderson LJ, SARS Working Group (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348:1953-1966
5. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS, Khattra J et al. (2003) The genome sequence of the SARS-associated coronavirus. Science 300:1399-1404
6. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC, Chan KH, Tsang DN, Yung RW, Ng TK, Yuen KY, SARS Study Group (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361:1319-1325
7. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300:1394-1399
8. Fouchier RA, Kuiken T, Schutten M, van Amerongen G, van Doornum GJ, van den Hoogen BG, Peiris M, Lim W, Stohr K, Osterhaus AD (2003) Aetiology: Koch's postulates fulfilled for SARS virus. Nature 423:240
9. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IF, Poon LL, Law KI, Tang BS, Hon TY, Chan CS, Chan KH, Ng JS, Zheng BJ, Ng WL, Lai RW, Guan Y, Yuen KY, HKU/UCH SARS Study Group (2003) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361:1767-1772
10. Li G, Chen X, Xu A (2003) Profile of specific antibodies to the SARS-associated coronavirus. N Engl J Med 349:508-509
11. Chen X, Zhou B, Li M, Liang X, Wang H, Yang G, Wang H, Le X (2004) Serology of severe acute respiratory syndrome: implications for surveillance and outcome. J Infect Dis 189:1158-1163
12. Leung GM, Chung PH, Tsang T, Lim W, Chan SK, Chau P, Donnelly CA, Ghani AC, Fraser C, Riley S, Ferguson NM, Anderson RM, Law YL, Mok T, Ng T, Fu A, Leung PY, Peiris JS, Lam TH, Hedley AJ (2004) SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis 10:1653-1656
13. Poon LL, Chan KH, Wong OK, Yam WC, Yuen KY, Guan Y, Lo YM, Peiris JS (2003) Early diagnosis of SARS coronavirus infection by real time RT-PCR. J Clin Virol 28:233-238
14. Poon LL, Chan KH, Wong OK, Cheung TK, Ng I, Zheng B, Seto WH, Yuen KY, Guan Y, Peiris JS (2004) Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin Chem 50:67-72
15. Chan KH, Poon LL, Cheng VC, Guan Y, Hung IF, Kong J, Yam LY, Seto WH, Yuen KY, Peiris JS (2004) Detection of SARS coronavirus in patients with suspected SARS. Emerg Infect Dis 10:294-299
16. Bressler AM, Nolte FS (2004) Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus. J Clin Microbiol 42:987-991
17. World Health Organization (2003) PCR primers for SARS developed by WHO network laboratories [monograph on the Internet]. Available at: http://www.who.int/csr/sars/primers/en/. Cited 20 April 2003
18. Liang WN, Mi J, Information Branch Joint Leadership Group of SARS Prevention and Control in Beijing (2003) Epidemiological features of severe acute respiratory syndrome in Beijing. Zhonghua Liu Xing Bing Xue Za Zhi 24:1096-1099
19. Zhou XZ, Zhao M, Wang FS, Jiang TJ, Li YG, Nie WM, Zhou ZP, Wang Y, He J, Fan R, Zhao JM, Zhang XW (2003) Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area. Zhonghua Yi Xue Za Zhi 83:1018-1022
20. Berger A, Drosten C, Doerr HW, Sturmer M, Preiser W (2004) Severe acute respiratory syndrome (SARS)-paradigm of an emerging viral infection. J Clin Virol 29:13-22
21. Mahony JB, Petrich A, Louie L, Song X, Chong S, Smieja M, Chernesky M, Loeb M, Richardson S, Ontario Laboratory Working Group for the Rapid Diagnosis of Emerging Infections (2004) Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol 42:1471-1476
22. Xu D, Zhang Z, Chu F, Li Y, Jin L, Zhang L, Gao GF, Wang FS (2004) Genetic variation of SARS coronavirus in Beijing hospital. Emerg Infect Dis 10:789-794
23. Li ZZ, Shen KL, Wei XM, Wang HL, Lu J, Tian H, Sun GQ, Zeng JJ, Hu YH, Zhao SY, Yin J, Feng XL, Jiang ZF, Yang YH (2003) Clinical analysis of pediatric SARS cases in Beijing. Zhonghua Er Ke Za Zhi 41:574-577
24. Leong HN, Chan KP, Khan AS, Oon L, Se-Thoe SY, Bai XL, Yeo D, Leo YS, Ang B, Ksiazek TG, Ling AE (2004) Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital. Emerg Infect Dis 10:1745-1750
25. Hsueh PR, Hsiao CH, Yeh SH, Wang WK, Chen PJ, Wang JT, Chang SC, Kao CL, Yang PC, SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital (2003) Microbiologic characteristics, serologic responses, and clinical manifestations in severe acute respiratory syndrome, Taiwan. Emerg Infect Dis 9:1163-1167
26. Xu D, Zhang Z, Wang FS (2004) SARS-associated coronavirus quasispeies in individual patients. New Engl J Med 350:1366-1367
27. Tian W, Deng YJ, Wu QF, Wang XM, Yang L, Zhang F, Liu CH, Bao QY, Wang J, Yang H, Liu M (2004) Isolation and identification of SARS-CoV from stool of SARS patients in different phase of disease. World Chin J Digestol 12:1246-1248